Eve Damiano

Eve Damiano has over 20 years of experience in the pharmaceutical and biotechnology industry. Eve began their career in 1981 as an Industrial Microbiologist for Polybac Corporation, where they were involved in the production of Polyseed and Nitroseed. In 1983, they joined Centocor as a regulatory specialist, where they were involved in the preparation of CM&C documentation to support international clinical trials and marketing applications for monoclonal antibody-derived biopharmaceuticals. From 1993 to 2001, they worked at US Bioscience/MedImmune in various regulatory roles, where they developed and executed global regulatory strategies for investigational and marketed new human drug products. Eve then moved to OraSure Technologies in 2001 as Vice President of Regulatory and Quality, where they managed processes related to maintaining compliance with ISO standards and Quality System/GMP regulations. In 2005, they became Vice President of Regulatory Affairs at Vicuron Pharmaceuticals (which became a subsidiary of Pfizer in September 2005). Eve also founded Damiano Consulting Associates, Inc. in 2005, where they served as President. In 2006, they joined Azevan Pharmaceuticals, Inc. as Sr. Vice President of Operations, where they were instrumental in advancing first two clinical candidates from the bench through completion of first-in-human clinical studies. In 2012, they joined Digestive Care, Inc. as Sr. Vice President of Operations. Most recently, they joined Annovis Bio, Inc. in 2022 as Sr. Vice President of Regulatory Operations.

Eve Damiano obtained their MS from Drexel University College of Medicine between 1985 and 1987. Eve obtained their BS in Biology from PennWest California between 1977 and 1980. Prior to that, they attended Emmaus High School between 1974 and 1977.